Latest News and Press Releases

MALVERN, Pa., Jan. 31, 2025 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies...

NTHU develops cellular transport "freeze" tech (RIVET) to control vesicle movement with light, offering new hope for treating diseases like COVID-19.

Inflammation resulting from activation of more than one type inflammasome and ASC specks contribute to development and progression of neurological disease

New York, United States, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Active medical implantable devices are made to be inserted into the body. These are designed to be injected into the body and remain there...

Vancouver, Dec. 12, 2023 (GLOBE NEWSWIRE) -- The global clinical biomarkers market is expected to reach a market size of USD 63.04 billion at a steady CAGR of 10.2% in 2032, according to latest...

Parkinson’s disease (“PD”), the second leading cause of neurodegeneration in the world, is characterized by progressive degeneration of nigrostriatal dopaminergic neurons and intracellular...

New York, USA, Aug. 25, 2021 (GLOBE NEWSWIRE) -- A latest report on the global neuromodulation devices market published by Research Dive sheds light on the impact of COVID-19 pandemic on the current...

CDKL5 Deficiency Disorder (“CDD”) is a severe neurodevelopmental epileptic encephalopathy disorder with no effective treatments or cureCollaboration creates opportunities to identify, validate, and...

CAMBRIDGE, MA--(Marketwired - September 29, 2016) - Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that it has partnered...